Go
Print

Chapter 69.04 RCW

INTRASTATE COMMERCE IN DRUGS AND COSMETICS

Sections

69.04.001Statement of purpose.
69.04.002Introductory.
69.04.003"Federal act" defined.
69.04.004"Intrastate commerce."
69.04.005"Sale."
69.04.006"Director."
69.04.007"Person."
69.04.008"Food."
69.04.009"Drugs."
69.04.010"Device."
69.04.011"Cosmetic."
69.04.012"Official compendium."
69.04.013"Label."
69.04.014"Immediate container."
69.04.015"Labeling."
69.04.016"Misleading labeling or advertisement," how determined.
69.04.017"Antiseptic" as germicide.
69.04.018"New drug" defined.
69.04.019"Advertisement."
69.04.020"Contaminated with filth."
69.04.040Prohibited acts.
69.04.050Remedy by injunction.
69.04.060Criminal penalty for violations.
69.04.070Additional penalty.
69.04.080Avoidance of penalty.
69.04.090Liability of disseminator of advertisement.
69.04.100Condemnation of adulterated or misbranded article.
69.04.110Embargo of articles.
69.04.120Procedure on embargo.
69.04.130Petitions may be consolidated.
69.04.140Claimant entitled to sample.
69.04.150Damages not recoverable if probable cause existed.
69.04.160Prosecutions.
69.04.170Minor infractions.
69.04.180Proceedings to be in name of state.
69.04.370Right of access for inspection.
69.04.410Drugs—Adulteration by harmful substances.
69.04.420Drugs—Adulteration for failure to comply with compendium standard.
69.04.430Drugs—Adulteration for lack of represented purity or quality.
69.04.440Drugs—Adulteration by admixture or substitution of ingredients.
69.04.450Drugs—Misbranding by false labeling.
69.04.460Packaged drugs—Misbranding.
69.04.470Drugs—Misbranding by lack of prominent label.
69.04.480Drugs—Misbranding for failure to state content of habit forming drug.
69.04.490Drugs—Misbranding by failure to show usual name and ingredients.
69.04.500Drugs—Misbranding by failure to give directions for use and warnings.
69.04.510Drugs—Misbranding for improper packaging and labeling.
69.04.520Drugs—Misbranding for failure to show possibility of deterioration.
69.04.530Drugs—Misbranding by misleading representation.
69.04.540Drugs—Misbranding by sale without prescription of drug requiring it.
69.04.550Drugs exempt if in transit for completion purposes.
69.04.560Dispensing of certain drugs exempt.
69.04.565DMSO (dimethyl sulfoxide) authorized.
69.04.570Introduction of new drug.
69.04.580Application for introduction.
69.04.590Effective date of application.
69.04.600Denial of application.
69.04.610Revocation of denial.
69.04.620Service of order of denial.
69.04.630Drug for investigational use exempt.
69.04.640Court review of denial.
69.04.650Dispensing of certain drugs exempt.
69.04.660Federally licensed drugs exempt.
69.04.670Cosmetics—Adulteration by injurious substances.
69.04.680Cosmetics—Misbranding by false label, etc.
69.04.690Cosmetics—Misbranding by lack of prominent label.
69.04.700Cosmetics exempt if in transit for completion purposes.
69.04.710Advertisement, when deemed false.
69.04.720Advertising of cure of certain diseases deemed false.
69.04.730Enforcement, where vested—Regulations.
69.04.740Regulations to conform with federal regulations.
69.04.750Hearings.
69.04.761Hearing on proposed regulation—Procedure.
69.04.770Review on petition prior to effective date.
69.04.780Investigations—Samples—Right of entry—Verified statements.
69.04.790Owner may obtain part of sample.
69.04.800Access to records of other agencies.
69.04.810Access to records of intrastate carriers.
69.04.820Right of entry to factories, warehouses, vehicles, etc.
69.04.830Publication of reports of judgments, orders and decrees.
69.04.840Dissemination of information.
69.04.850Construction—1945 c 257.
69.04.860Effective date of chapter—1945 c 257.
69.04.880Civil penalty.

NOTES:

Chapter 69.07 RCW does not impair authority of director or department under this chapter: RCW 69.07.160.
Dairies and dairy products: Chapter 15.36 RCW.
Food processing inspection account: RCW 69.07.120.
Patent medicine peddlers: Chapter 18.64 RCW.
Site Contents
Selected content listed in alphabetical order under each group



Translate